These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 17966721)

  • 1. 90Yttrium microspheres for nonresectable liver cancer: the University of Connecticut Health Center experience.
    Rowe BP; Weiner R; Foster J; Dowsett R
    Conn Med; 2007 Oct; 71(9):523-8. PubMed ID: 17966721
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of nonresectable hepatocellular carcinoma with intrahepatic 90Y-microspheres.
    Dancey JE; Shepherd FA; Paul K; Sniderman KW; Houle S; Gabrys J; Hendler AL; Goin JE
    J Nucl Med; 2000 Oct; 41(10):1673-81. PubMed ID: 11037997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective internal radiation therapy (SIRT) with 90Yttrium microspheres for extensive colorectal liver metastases.
    Stubbs RS; Cannan RJ; Mitchell AW
    Hepatogastroenterology; 2001; 48(38):333-7. PubMed ID: 11379303
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective internal radiation therapy with 90Y microspheres for colorectal liver metastases: single-centre experience with 100 patients.
    Stubbs RS; O'Brien I; Correia MM
    ANZ J Surg; 2006 Aug; 76(8):696-703. PubMed ID: 16916386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres.
    Lau WY; Ho S; Leung TW; Chan M; Ho R; Johnson PJ; Li AK
    Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):583-92. PubMed ID: 9486608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What determines survival duration in hepatocellular carcinoma treated with intraarterial Yttrium-90 microspheres?
    Lau WY; Ho S; Leung WT; Chan M; Lee WY; Johnson PJ
    Hepatogastroenterology; 2001; 48(38):338-40. PubMed ID: 11379304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective internal radiation therapy with SIR-Spheres in patients with nonresectable liver tumors.
    Pöpperl G; Helmberger T; Münzing W; Schmid R; Jacobs TF; Tatsch K
    Cancer Biother Radiopharm; 2005 Apr; 20(2):200-8. PubMed ID: 15869456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and imaging experience with yttrium-90 microspheres in the management of unresectable liver tumours.
    Jiao LR; Szyszko T; Al-Nahhas A; Tait P; Canelo R; Stamp G; Wasan H; Lowdell C; Philips R; Thillainayagam A; Bansi D; Rubello D; Limongelli P; Woo K; Habib NA
    Eur J Surg Oncol; 2007 Jun; 33(5):597-602. PubMed ID: 17433608
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective analysis of selective internal radiation therapy (SIRT) with yttrium-90 microspheres in patients with unresectable hepatic malignancies.
    Omed A; Lawrance JA; Murphy G; Laasch HU; Wilson G; Illidge T; Tipping J; Zivanovic M; Jeans S
    Clin Radiol; 2010 Sep; 65(9):720-8. PubMed ID: 20696299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicentric phase II clinical trial on intra-arterial hepatic radiotherapy with 90yttrium SIR-spheres in unresectable, colorectal liver metastases refractory to i.v. chemotherapy: preliminary results on toxicity and response rates.
    Mancini R; Carpanese L; Sciuto R; Pizzi G; Golfieri R; Giampalma L; Cappelli A; Galaverni MC; Blotta A; Fiore F; Izzo F; Lastoria S; Mastro A; Di Marzo M; Cagol PP; Gasparini D; Geatti O; Bacchetti S; Pasqual E; Zeuli M; Paoletti G; Garufi C; Cosimelli M;
    In Vivo; 2006; 20(6A):711-4. PubMed ID: 17203751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Internal pair production of 90Y permits hepatic localization of microspheres using routine PET: proof of concept.
    Gates VL; Esmail AA; Marshall K; Spies S; Salem R
    J Nucl Med; 2011 Jan; 52(1):72-6. PubMed ID: 21149493
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver radioembolization using 90Y resin microspheres in elderly patients: tolerance and outcome.
    Iñarrairaegui M; Bilbao JI; Rodríguez M; Benito A; Sangro B
    Hosp Pract (1995); 2010; 38(3):103-9. PubMed ID: 20890058
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survival.
    Bangash AK; Atassi B; Kaklamani V; Rhee TK; Yu M; Lewandowski RJ; Sato KT; Ryu RK; Gates VL; Newman S; Mandal R; Gradishar W; Omary RA; Salem R
    J Vasc Interv Radiol; 2007 May; 18(5):621-8. PubMed ID: 17494843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Profound transient thrombocytopenia associated with 90Yttrium microsphere therapy for inoperable hepatoma.
    Yang CW; Yen HH; Su WW; Chen YY; Soon MS
    South Med J; 2010 Dec; 103(12):1264-8. PubMed ID: 21037524
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective intraarterial radionuclide therapy with Yttrium-90 (Y-90) microspheres for unresectable primary and metastatic liver tumors.
    Kucuk ON; Soydal C; Lacin S; Ozkan E; Bilgic S
    World J Surg Oncol; 2011 Aug; 9():86. PubMed ID: 21819613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Underlying liver disease influences volumetric changes in the spared hemiliver after selective internal radiation therapy with 90Y in patients with hepatocellular carcinoma.
    Teo JY; Goh BK; Cheah FK; Allen JC; Lo RH; Ng DC; Goh AS; Khor AY; Sim HS; Ng JJ; Chow PK
    J Dig Dis; 2014 Aug; 15(8):444-50. PubMed ID: 24828952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioembolization using 90Y-resin microspheres for patients with advanced hepatocellular carcinoma.
    Sangro B; Bilbao JI; Boan J; Martinez-Cuesta A; Benito A; Rodriguez J; Panizo A; Gil B; Inarrairaegui M; Herrero I; Quiroga J; Prieto J
    Int J Radiat Oncol Biol Phys; 2006 Nov; 66(3):792-800. PubMed ID: 16904840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 90Y microsphere (TheraSphere) treatment for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by [18F]fluorodeoxyglucose positron emission tomography and computed tomographic imaging.
    Lewandowski RJ; Thurston KG; Goin JE; Wong CY; Gates VL; Van Buskirk M; Geschwind JF; Salem R
    J Vasc Interv Radiol; 2005 Dec; 16(12):1641-51. PubMed ID: 16371530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radioembolization in patients with hepatic metastases from breast cancer.
    Jakobs TF; Hoffmann RT; Fischer T; Stemmler HJ; Tatsch K; La Fougere C; Murthy R; Reiser MF; Helmberger TK
    J Vasc Interv Radiol; 2008 May; 19(5):683-90. PubMed ID: 18440456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival.
    Salem R; Lewandowski RJ; Atassi B; Gordon SC; Gates VL; Barakat O; Sergie Z; Wong CY; Thurston KG
    J Vasc Interv Radiol; 2005 Dec; 16(12):1627-39. PubMed ID: 16371529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.